Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/1998
12/23/1998EP0648276B1 Monoclonal antibodies to glycoprotein p
12/23/1998EP0631474B1 Cyclic anti-tumor promoter compounds, compositions and methods for production and use
12/23/1998EP0553294B1 The manufacture of compositions for the treatment of cell proliferation disorders
12/23/1998EP0473721B1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
12/23/1998CN1202934A Delivery of biologically active polypeptides
12/23/1998CN1202932A Therapeutic antiangiogenic compositions and methods
12/23/1998CN1202931A Tumour vaccine and process for the preparation thereof
12/23/1998CN1202907A Cyclopeptide derivatives
12/23/1998CN1202904A Cyclopeptolides
12/23/1998CN1202903A Targeted cytotoxic anthracycline analogs
12/23/1998CN1202900A Inhibition of tumor growth by antisense oligonucleotides for IL-8 and Il-8 receptor
12/23/1998CN1202896A Purine derivatives and processes for their preparation
12/23/1998CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists
12/23/1998CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds
12/23/1998CN1202885A 25-hydroxy-16-one-26,27-bishomo-cholecalciferols
12/23/1998CN1202882A New LH-RH antigonists with improved effectiveness
12/23/1998CN1202834A Hollow-tube brachytherapy device
12/23/1998CN1202827A 1,2,4-benzotriazine oxides formulations
12/23/1998CN1202799A Method for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains
12/23/1998CN1041310C Process for obtaining 10-deacetylbaccatin III
12/23/1998CN1041281C Polymer-bound taxol derivatives
12/23/1998CA2294593A1 Agent for diagnosing and treating malignant tumors
12/23/1998CA2294569A1 Secreted proteins and polynucleotides encoding them
12/23/1998CA2294563A1 New human lysophospholipase
12/23/1998CA2294051A1 Adjuvant compositions for vaccines
12/23/1998CA2294047A1 Crystalline roxifiban
12/23/1998CA2293998A1 Irs-p53h, human insulin receptor tyrosine kinase substrate
12/23/1998CA2293614A1 Adjuvant compositions for vaccines
12/23/1998CA2293482A1 Carboxy piperidylacetamide tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors)
12/23/1998CA2292608A1 Therapeutic systems for activation prodrugs
12/23/1998CA2289100A1 Quinoline derivatives as pde iv and/or tnf inhibitors
12/22/1998US5852210 Cinnamic acid derivatives
12/22/1998US5852204 Pyrrolo 3,2-b-!-carbazoles and 1H 1!benzothieno 2,3-f! indoles having anti-tumor activity
12/22/1998US5852059 Use of droloxifene for the treatment of protastic disease, endometriosis and obesity
12/22/1998US5852057 Anticarcinogenic drug composition
12/22/1998US5852056 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/22/1998US5852052 Treatment of lyso paf-mediated mental or neuronal disorders with lyso paf or paf antagonists and procedure for determining their efficacy
12/22/1998US5852034 Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors
12/22/1998US5852033 Methods of treatment using lamellarin-class alkaloids
12/22/1998US5852002 Treatment of conditions and disease
12/22/1998US5851999 FLK-1 is a receptor for vascular endothelial growth factor
12/22/1998US5851993 Suppression of tumor cell growth by syndecan-1 ectodomain
12/22/1998US5851987 Human tumor-associated Kazal inhibitor-like polypeptides and encoding polynucleotides
12/22/1998US5851818 Condensed plasmid-liposome complex for transfection
12/22/1998US5851793 Recombinant DNA encoding receptor protein for human B-cell stimulatory factor-2
12/22/1998US5851786 Product and process to regulate actin polymerization
12/22/1998US5851775 β-catenin, Tcf-4, and APC interact to prevent cancer
12/22/1998US5851526 Methods of treating colon cancer utilizing tumor-specific antibodies
12/22/1998US5851523 Isolated, peptides derived from MAGE tumor rejection antigen precursors which complex with HLA-A2 molecules and uses thereof
12/22/1998CA1340286C Pt(iv) complexes
12/22/1998CA1340281C Process for preparing and purifying alpha-interferon
12/18/1998CA2239605A1 Novel g-protein coupled receptor (h7tba62)
12/17/1998WO1998056941A1 Carbohydrate complex extracted from mycobacterium tuberculosis and process for the preparation thereof
12/17/1998WO1998056925A1 Human protein phosphatase ii-c-like protein
12/17/1998WO1998056919A2 Methods and reagents for vaccination which generate a cd8 t cell immune response
12/17/1998WO1998056911A1 Human phosphatidylinositol transfer protein gamma
12/17/1998WO1998056910A1 DETECTION OF LOSS OF THE WILD-TYPE huBUB1 GENE
12/17/1998WO1998056909A2 Secreted proteins and polynucleotides encoding them
12/17/1998WO1998056898A2 Human peroxisomal thioesterase
12/17/1998WO1998056820A1 Hm74a receptor
12/17/1998WO1998056818A1 Human l105 proteins and polynucleotides encoding same
12/17/1998WO1998056783A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same
12/17/1998WO1998056425A1 Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs
12/17/1998WO1998056424A1 Biologically active materials
12/17/1998WO1998056420A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998WO1998056419A1 Methods of delaying development of hmfg-associated tumors using anti-idiotype antibody 11d10
12/17/1998WO1998056416A1 Immunogenic compositions for induction of anti-tumor immunity
12/17/1998WO1998056387A1 Method of treatment of liver tumours and pharmaceutical compositions for use therein
12/17/1998WO1998056383A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998WO1998056377A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998WO1998056376A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998WO1998056370A2 Therapeutic nanospheres
12/17/1998WO1998056358A1 Rapamycin formulations for oral administration
12/17/1998WO1998056248A1 A novel method of detecting and treating cancer
12/17/1998WO1998051325A3 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
12/17/1998WO1998033919A3 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use
12/17/1998WO1998030586A3 Diagnostics and therapy of epstein-barr virus in autoimmune disorders
12/17/1998WO1998023299A3 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
12/17/1998CA2303268A1 Therapeutic nanospheres
12/17/1998CA2295982A1 Human l105 proteins and polynucleotides encoding same
12/17/1998CA2295704A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
12/17/1998CA2294069A1 Methods of delaying development of hmfg-associated tumors using anti-idiotype antibody 11d10
12/17/1998CA2294057A1 Novel pyrazole and pyrazoline substituted compounds
12/17/1998CA2293700A1 Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs
12/17/1998CA2293439A1 Ganglioside immunostimulating complexes and uses thereof
12/17/1998CA2293400A1 Novel heteroaryl compounds for the modulation of protein tyrosine enzyme related cellular signal transduction
12/17/1998CA2293363A1 Secreted proteins and polynucleotides encoding them
12/17/1998CA2293250A1 Human phosphatidylinositol transfer protein gamma
12/17/1998CA2293248A1 Human protein phosphatase ii-c-like protein
12/17/1998CA2289471A1 A novel method of detecting and treating cancer
12/16/1998EP0884388A1 Transgenic plants containing recombinant mistletoe lectin (rML)
12/16/1998EP0884387A2 Human 7-transmembrane receptor HLWAR77
12/16/1998EP0884386A1 Sodium channel receptor
12/16/1998EP0884385A1 Intracellular modulators of apoptopic cell death pathways
12/16/1998EP0884329A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
12/16/1998EP0884308A2 A method of preparing 16-dehydro vitamin D compounds
12/16/1998EP0884056A1 Vaccines containing a saponin and a sterol
12/16/1998EP0884051A1 Cancerous metastasis inhibitors containing uracil derivatives
12/16/1998EP0884042A1 Medicament and method of treating an organism with medicaments
12/16/1998EP0883685A1 Method for obtaining microorganisms capable of producing antitumor molecules
1 ... 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 ... 2211